These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

270 related items for PubMed ID: 27039757

  • 1. Expression of p53 Breast Cancer in Kurdish Women in the West of Iran: a Reverse Correlation with Lymph Node Metastasis.
    Payandeh M, Sadeghi M, Sadeghi E, Madani SH.
    Asian Pac J Cancer Prev; 2016; 17(3):1261-4. PubMed ID: 27039757
    [Abstract] [Full Text] [Related]

  • 2. Comparisons of p53, KI67 and BRCA1 expressions in patients with different molecular subtypes of breast cancer and their relationships with pathology and prognosis.
    Li Y, Zhang X, Qiu J, Pang T, Huang L, Zeng Q.
    J BUON; 2019; 24(6):2361-2368. PubMed ID: 31983107
    [Abstract] [Full Text] [Related]

  • 3. Prognostic value of phosphorylated HER2 in HER2-positive breast cancer patients treated with adjuvant trastuzumab.
    Kurebayashi J, Kanomata N, Yamashita T, Shimo T, Mizutoh A, Moriya T, Sonoo H.
    Breast Cancer; 2015 May; 22(3):292-9. PubMed ID: 23749689
    [Abstract] [Full Text] [Related]

  • 4. Interrelationships Between Ki67, HER2/neu, p53, ER, and PR Status and Their Associations With Tumor Grade and Lymph Node Involvement in Breast Carcinoma Subtypes: Retrospective-Observational Analytical Study.
    Shokouh TZ, Ezatollah A, Barand P.
    Medicine (Baltimore); 2015 Aug; 94(32):e1359. PubMed ID: 26266392
    [Abstract] [Full Text] [Related]

  • 5. Hormone receptor and HER2 status in patients with breast cancer by races in southeastern Turkey.
    Kuzhan A, Adli M, Eryigit Alkis H, Caglayan D.
    J BUON; 2013 Aug; 18(3):619-22. PubMed ID: 24065473
    [Abstract] [Full Text] [Related]

  • 6. Ki67 index in breast cancer: correlation with other prognostic markers and potential in pakistani patients.
    Haroon S, Hashmi AA, Khurshid A, Kanpurwala MA, Mujtuba S, Malik B, Faridi N.
    Asian Pac J Cancer Prev; 2013 Aug; 14(7):4353-8. PubMed ID: 23992002
    [Abstract] [Full Text] [Related]

  • 7. Changes in the ER, PgR, HER2, p53 and Ki-67 biological markers between primary and recurrent breast cancer: discordance rates and prognosis.
    Nishimura R, Osako T, Okumura Y, Tashima R, Toyozumi Y, Arima N.
    World J Surg Oncol; 2011 Oct 17; 9():131. PubMed ID: 22004841
    [Abstract] [Full Text] [Related]

  • 8. Tumor-infiltrating lymphocytes, tumor characteristics, and recurrence in patients with early breast cancer.
    Kim ST, Jeong H, Woo OH, Seo JH, Kim A, Lee ES, Shin SW, Kim YH, Kim JS, Park KH.
    Am J Clin Oncol; 2013 Jun 17; 36(3):224-31. PubMed ID: 22495453
    [Abstract] [Full Text] [Related]

  • 9. Comparison of ER, PR and HER-2/neu (C-erb B 2) reactivity pattern with histologic grade, tumor size and lymph node status in breast cancer.
    Azizun-Nisa, Bhurgri Y, Raza F, Kayani N.
    Asian Pac J Cancer Prev; 2008 Jun 17; 9(4):553-6. PubMed ID: 19256737
    [Abstract] [Full Text] [Related]

  • 10. Ki67 expression in breast cancer. Correlation with prognostic markers and clinicopathological parameters in Saudi patients.
    Elkablawy MA, Albasri AM, Mohammed RA, Hussainy AS, Nouh MM, Alhujaily AS.
    Saudi Med J; 2016 Feb 17; 37(2):137-41. PubMed ID: 26837394
    [Abstract] [Full Text] [Related]

  • 11. Association of Histopathological Markers with Clinico- Pathological Factors in Mexican Women with Breast Cancer.
    Bandala C, De la Garza-Montano P, Cortes-Algara A, Cruz-Lopez J, Dominguez-Rubio R, Gonzalez-Lopez JN, Cardenas-Rodriguez N, Alfaro-Rodriguez A, Salcedo M, Floriano-Sanchez E, Lara-Padilla E.
    Asian Pac J Cancer Prev; 2015 Feb 17; 16(18):8397-403. PubMed ID: 26745092
    [Abstract] [Full Text] [Related]

  • 12. FOXA1 expression after neoadjuvant chemotherapy is a prognostic marker in estrogen receptor-positive breast cancer.
    Kawase M, Toyama T, Takahashi S, Sato S, Yoshimoto N, Endo Y, Asano T, Kobayashi S, Fujii Y, Yamashita H.
    Breast Cancer; 2015 May 17; 22(3):308-16. PubMed ID: 23771556
    [Abstract] [Full Text] [Related]

  • 13. Immunohistochemical profile of breast cancer patients at a tertiary care hospital in South India.
    Ambroise M, Ghosh M, Mallikarjuna VS, Kurian A.
    Asian Pac J Cancer Prev; 2011 May 17; 12(3):625-9. PubMed ID: 21627355
    [Abstract] [Full Text] [Related]

  • 14. Histological grade provides significant prognostic information in addition to breast cancer subtypes defined according to St Gallen 2013.
    Ehinger A, Malmström P, Bendahl PO, Elston CW, Falck AK, Forsare C, Grabau D, Rydén L, Stål O, Fernö M, South and South-East Swedish Breast Cancer Groups.
    Acta Oncol; 2017 Jan 17; 56(1):68-74. PubMed ID: 27762648
    [Abstract] [Full Text] [Related]

  • 15. Hormone receptors and HER2 expression in primary breast carcinoma and corresponding lymph node metastasis: do we need both?
    Raica M, Cîmpean AM, Ceausu RA, Fulga V, Nica C, Rudico L, Saptefrati L.
    Anticancer Res; 2014 Mar 17; 34(3):1435-40. PubMed ID: 24596391
    [Abstract] [Full Text] [Related]

  • 16. Correlations between HER2 Expression and Other Prognostic Factors in Breast Cancer: Inverse Relations with the Ki-67 Index and P53 Status.
    Payandeh M, Shahriari-Ahmadi A, Sadeghi M, Sadeghi E.
    Asian Pac J Cancer Prev; 2016 Mar 17; 17(3):1015-8. PubMed ID: 27039719
    [Abstract] [Full Text] [Related]

  • 17. Prognostic significance of geminin expression levels in Ki67-high subset of estrogen receptor-positive and HER2-negative breast cancers.
    Yagi T, Inoue N, Yanai A, Murase K, Imamura M, Miyagawa Y, Enomoto Y, Nishimukai A, Takatsuka Y, Hirota S, Akazawa K, Miyoshi Y.
    Breast Cancer; 2016 Mar 17; 23(2):224-30. PubMed ID: 25082658
    [Abstract] [Full Text] [Related]

  • 18. Estrogen receptor and progesterone receptor status in breast cancer in relation to age, histological grade, size of lesion and lymph node involvement.
    Sofi GN, Sofi JN, Nadeem R, Shiekh RY, Khan FA, Sofi AA, Bhat HA, Bhat RA.
    Asian Pac J Cancer Prev; 2012 Mar 17; 13(10):5047-52. PubMed ID: 23244108
    [Abstract] [Full Text] [Related]

  • 19. Subtype classification for prediction of prognosis of breast cancer from a biomarker panel: correlations and indications.
    Chen C, Yuan JP, Wei W, Tu Y, Yao F, Yang XQ, Sun JZ, Sun SR, Li Y.
    Int J Nanomedicine; 2014 Mar 17; 9():1039-48. PubMed ID: 24591826
    [Abstract] [Full Text] [Related]

  • 20. Correlation of E-cadherin expression and routine immunohistochemistry panel in breast invasive ductal carcinoma.
    Mohammadizadeh F, Ghasemibasir H, Rajabi P, Naimi A, Eftekhari A, Mesbah A.
    Cancer Biomark; 2009 Mar 17; 5(1):1-8. PubMed ID: 19242056
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.